Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clesrovimab for Prevention of RSV Disease in Healthy Infants.
Journal: The New England journal of medicine
Published: September 17, 2025
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
Journal: The Journal of infectious diseases
Published: July 11, 2024
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Journal: American journal of clinical dermatology
Published: March 27, 2020
2'-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With Bifidobacterium lactis: A Randomized Controlled Trial.
Journal: Global pediatric health
Published: August 10, 2018
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.
Journal: Human vaccines & immunotherapeutics
Published: May 06, 2016
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label Trial.
Journal: The Pediatric infectious disease journal
Published: October 20, 2015
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.
Journal: Human vaccines & immunotherapeutics
Published: November 14, 2013
Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children.
Journal: Human vaccines & immunotherapeutics
Published: June 08, 2013
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Journal: The Pediatric infectious disease journal
Published: May 25, 2012
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers.
Journal: Vaccine
Published: December 19, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026